Medical devices, healthcare technology and the business of care
510(k) clearance · K261937

PacTemp Automix NE

The Belport Company Inc., DBA Gingi-Pak · Decision date Aug 7, 2026

FDA DECISIONK261937

What did the FDA decide?

FDA records K261937 as a 510(k) premarket notification, with a decision dated Aug 7, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Aug 7, 2026

FDA source record

Regulatory record facts

Identifier
K261937
Regulatory pathway
510(k) premarket notification
Product code
EMA
Decision code
SESE
Decision date
Aug 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cement, Dental.

Product code
EMA
FDA device class
2

FDA decision timeline

  1. K261937 received

    Application receipt date recorded by FDA.

  2. K261937 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code EMA

Product / regulatory recordCompanyPathwayDecision dateSource
Spident Co., Ltd.510(k) clearanceSep 25, 2026FDA
Any-CemK254201
Mediclus Co., Ltd.510(k) clearanceAug 13, 2026FDA
DIA-CEMK261166
DiaDent Group International510(k) clearanceJul 9, 2026FDA
GC America, Inc.510(k) clearanceMay 18, 2026FDA
INTER-MED, INC.510(k) clearanceApr 15, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

The Belport Company Inc., DBA Gingi-Pak

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Camarillo, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records